Catalys Pacific, LLC reported 2 holdings worth US$229M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 5, 2026
Catalys Pacific, LLC reported 2 holdings worth US$229M as of Jun 30, 2026. Largest: Mineralys Therapeutics, Inc. and Phathom Pharmaceuticals, Inc. Filed Aug 5, 2026 (Form 13F).
- Holdings
- 2
- Value as reported
- US$229M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. | 7.9M | US$213M | 92.9% |
| Phathom Pharmaceuticals, Inc. | 1.49M | US$16.2M | 7.1% |